CD20 monoclonal antibodies
What are CD20 monoclonal antibodies?
Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes. Natural antibodies are proteins made by the B-lymphocytes in response to antigens. Each B-cell makes only one type of antibody. For therapeutic purposes a significant amount of a particular antibody is needed. These are obtained from a culture that gives a one type of antibody, which are called monoclonal antibodies. CD20 monoclonal antibodies are targeted against B-cell antigens, and were originally developed to treat B-cell Non-Hodgkin's lymphoma.
List drug with CD20 monoclonal antibodies
Drug Name |
---|
Columvi Generic name: Glofitamab-gxbm |
Briumvi Generic name: Ublituximab |
Epcoritamab-bysp Generic name: Epcoritamab-bysp |
Epkinly Generic name: Epcoritamab-bysp |
Gazyva Generic name: Obinutuzumab |
Glofitamab-gxbm Generic name: Glofitamab-gxbm |
Hyaluronidase and rituximab Generic name: Hyaluronidase And Rituximab |
Obinutuzumab Generic name: Obinutuzumab |
Ocrelizumab Generic name: Ocrelizumab |
Ocrevus Generic name: Ocrelizumab |
Riabni Generic name: Rituximab |
Riabni (Rituximab Intravenous) Generic name: Rituximab |
Riabni (Rituximab-arrx Intravenous) Generic name: Rituximab-arrx |
Rituxan Hycela Generic name: Hyaluronidase And Rituximab |
Rituximab and hyaluronidase human, recombinant Generic name: Rituximab And Hyaluronidase Human, Recombinant |
Ruxience Generic name: Rituximab |
Ruxience (Rituximab Intravenous) Generic name: Rituximab |
Ruxience (Rituximab-pvvr Intravenous) Generic name: Rituximab-pvvr |
Truxima Generic name: Rituximab |
Truxima (Rituximab Intravenous) Generic name: Rituximab |
Truxima (Rituximab-abbs Intravenous) Generic name: Rituximab-abbs |
Ublituximab Generic name: Ublituximab |
Ublituximab-xiiy Generic name: Ublituximab-xiiy |
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions